Search for: "Hyman Phelps McNamara" Results 121 - 140 of 234
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Feb 2023, 7:44 pm by Hyman Phelps McNamara
Hyman, Phelps & McNamara (“HPM”) Director Larry Houck will present “Prescribing Red Flags, Corresponding Responsibility and DEA Investigations: What’s a Pharmacist To Do? [read post]
13 Nov 2023, 3:15 am by Hyman Phelps McNamara
 Program highlights include: Spotlight on FDA’s Newly Proposed ACNU Rule Updates on Monograph Reform Implementation Advertising, Labeling and Claims Substantiation Essentials Exploring the Recent Wave of Rx-OTC Drug Switches Hyman, Phelps & McNamara, P.C. [read post]
12 Apr 2023, 5:43 pm by Hyman Phelps McNamara
On Thursday, April 20, from 1:30-3:00pm, John Claud of Hyman, Phelps & McNamara, P.C. will present a webinar entitled “Medical Device Enforcement: Latest Developments from the FDA, DOJ and FTC. [read post]
29 May 2012, 12:08 pm
The Instructors David ACHESON, Partner at Leavitt Partners, former Assistant Commissioner for Food Protection, FDALes BOURQUIN, Professor of Food Safety, Michigan State UniversityRicardo CARVAJAL, Attorney and Director, Hyman, Phelps & McNamara, P.C.Roger CLEMENS, Chief Scientific Officer, Horn; President, Institute of Food TechnologistsNicole COUTRELIS, Lawyer and Partner, Coutrelis & Associes, Paris and BrusselsNeal FORTIN, Attorney, Professor and Director,… [read post]
16 Jan 2025, 8:32 pm by Hyman Phelps McNamara
Hyman, Phelps & McNamara PC, (HPM), which will mark its 45th Anniversary on March 17, 2025, is pleased to announce that it is increasing its directors, counsel, and associates as it starts the year. [read post]
24 Jan 2024, 2:48 am by Hyman Phelps McNamara
Karst (Director, Hyman, Phelps & McNamara, P.C.) and Stacy Cline Amin (Partner, Morrison & Foerster (Former Chief Counsel, U.S. [read post]
26 Sep 2023, 2:23 am by Hyman Phelps McNamara
  Non-compliant facilities face: Increased patient and employee health risks — in some cases even overdose deaths Multi-million-dollar settlements — and these amounts have been increasing each year Significant long-term compliance costs to meet the requirements of government settlement agreements Erosion of public trust and confidence in affected hospitals and pharmacies Unwanted local and national publicity Hyman, Phelps & McNamara (HP&M) invites… [read post]
29 Jan 2023, 6:09 pm by Kurt R. Karst
The analysis was prepared for Pharma Conference’s conference on February 8 and 9 in San Diego (“Current Hot GMP Topics”), linked here, where Hyman, Phelps & McNamara, P.C., Director Doug Farquhar will be presenting on three areas: enforcement areas of primary concern, the conduct of internal investigations, and contacting FDA about inspections. [read post]
8 Aug 2012, 4:30 am by Frances Zacher
” If you’re up for some light reading, the FDA Law Blog provides a link to a 75-page “summary” of all 11 titles of the law by the FDA powerhouse firm Hyman, Phelps & McNamara, which can also be found here. [read post]
11 Jul 2012, 1:25 pm by FDABlog HPM
Hyman, Phelps & McNamara, P.C. has prepared a detailed summary and analysis of FDASIA. [read post]